5-Amino-1MQ vs MOTS-c: Which Is the Better Fat Burner?
5-Amino-1MQ and MOTS-c both appear in fat loss research, but they work through completely different paths.
Quick Answer
5-Amino-1MQ targets fat cells directly by blocking an enzyme that normally slows fat burning. MOTS-c works at the cell's energy factory and improves how the whole body uses fuel, particularly during exercise. If your goal is fat cell metabolism, 5-Amino-1MQ is the more direct tool. If your goal is whole-body energy efficiency or blood sugar control, MOTS-c is the one getting more attention.
What Is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule, not a peptide. It blocks an enzyme called nicotinamide N-methyltransferase (NNMT) inside fat cells.
NNMT normally breaks down NAD+, a molecule your cells use for energy and fat-burning signals. When NNMT is blocked, NAD+ levels in fat cells rise, and those cells get stronger signals to break down stored fat (source).
Most of the evidence for this comes from animal studies. Human trial data is very limited as of mid-2026.
What Is MOTS-c?
MOTS-c is a peptide produced inside the mitochondria, which are the tiny structures inside cells that turn food into usable energy.
It was discovered relatively recently and belongs to a class called mitochondria-derived peptides. MOTS-c appears to improve how cells respond to insulin, helping them take in and burn fuel more efficiently .
Exercise seems to raise natural MOTS-c levels. Injectable MOTS-c is studied as a way to amplify that effect. Human data is limited, though some early trials in older adults exist .
How Do They Differ?
| Feature | 5-Amino-1MQ | MOTS-c |
|---|---|---|
| Type | Small molecule (oral) | Peptide (injectable) |
| Mechanism | Blocks NNMT enzyme; raises NAD+ in fat cells | Improves cellular fuel use; supports insulin sensitivity |
| Primary use | Direct fat cell metabolism | Whole-body energy efficiency, metabolic health |
| Typical research dose | 50 to 100 mg oral | 5 to 10 mg injectable |
| Onset | Not well established in humans | Not well established in humans |
| Evidence level | Mostly animal data; very limited human trials | Mostly animal data; some early human aging research |
Mechanism. 5-Amino-1MQ goes straight for the fat cell. It blocks NNMT, which raises NAD+ locally, and that shift signals the fat cell to burn its stored contents more aggressively .
MOTS-c works at a broader level. It appears to activate a metabolic sensor inside cells called AMPK (adenosine monophosphate-activated protein kinase), which tells cells to burn fuel and improve how they handle blood sugar .
Administration. 5-Amino-1MQ is taken orally. MOTS-c requires injection. That difference alone matters a lot to many people.
Evidence level. Both compounds have an honest limitation. The bulk of data comes from mice and rats. MOTS-c has some early human studies focused on exercise performance and aging. 5-Amino-1MQ human trials are sparse. Neither compound is FDA-approved.
Tracking either compound carefully over time helps you notice what is actually changing. DoseVault is a free tool for logging doses, timing, and how you feel each day.
Can You Stack 5-Amino-1MQ and MOTS-c?
Possibly, and the theory is reasonable. They hit different targets: one works inside fat cells, the other works at the energy factory level.
There is no published research on combining them. Anyone considering this combination should work with a licensed clinician who can monitor bloodwork and metabolic markers.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule that blocks the NNMT enzyme in fat cells. Blocking NNMT raises NAD+ levels and signals fat cells to break down stored fat.
What is MOTS-c?
MOTS-c is a peptide made inside the mitochondria, the cell's energy factory. It helps cells burn fuel more efficiently, especially during exercise, and may improve insulin sensitivity.
Can you stack 5-Amino-1MQ and MOTS-c?
They target different pathways, so stacking is theoretically complementary. However, no published research on combining them exists. Anyone considering a stack should consult a licensed clinician.
Which has more human research, 5-Amino-1MQ or MOTS-c?
Both have mostly animal data. MOTS-c has some early human research on exercise and aging, while 5-Amino-1MQ human trials are very limited. Neither has broad clinical trial support.
Which Do People Pick, and When?
This is general guidance only, not personalized medical advice. Talk to a licensed clinician before starting any protocol.
People tend to reach for 5-Amino-1MQ when:
- The goal is specifically targeting fat cell metabolism
- They prefer an oral compound over injections
- They want to pair it with a caloric deficit for a direct fat-loss focus
People tend to reach for MOTS-c when:
- The goal includes metabolic health and blood sugar regulation alongside fat loss
- Exercise performance and energy efficiency are priorities
- They are comfortable with injectable peptides
People explore both when:
- They want to address fat cell metabolism and whole-body fuel efficiency at the same time
- They have a clinician supervising their protocol and monitoring labs
Related
- 5-Amino-1MQ
- MOTS-c
- 5-Amino-1MQ vs Tesamorelin
- Epithalon vs MOTS-c
- Humanin vs MOTS-c
- How to Reconstitute MOTS-c
- MOTS-c Dosage
This page is for educational purposes only. It is not medical advice and does not replace a conversation with a licensed healthcare provider. These compounds are not FDA-approved for general use. Do not use them to diagnose, address, or manage any health condition.
Built by medical professionals, gym rats, and experienced biohackers
Log your 5-Amino-1MQ or MOTS-c protocol with DoseVault. Track doses, timing, and your body's response all in one place.